Keywords
Lipoprotein
atherosclerosis
leprosy
atherosclerosis
leprosy
How to Cite
1.
Dalpino D, Magna LA, Opromolla DVA. Avaliação dos níveis de lipídeos, lipoproteínas, apoproteínas e o papel da lipoproteína(a) no desenvolvimento de aterosclerose e alterações fibrinolíticas nos pacientes portadores de hanseníase virchoviana. Hansen. Int. [Internet]. 1997 Nov. 30 [cited 2024 Dec. 27];22(2):20-3. Available from: https://periodicos.saude.sp.gov.br/hansenologia/article/view/36452
Abstract
Alteration in the lipid metabolism of lepromatous leprosy patients has been reported by several workers. Cardiovascular diseases, especially atherosclerosis, is frequentely referred in the anatomopathological description of lepromatous leprosy in patients from the Instituto Lauro de Souza Lima, Bauru. A subnormal level of serum total cholesterol has been observed in active lepromatous leprosy. Concerned of this fact, we determined the blood level of the protector and risk factor of the cardiovascular diseases in 82 lepromatous leprosy inpatients from that Institute and outpatients of the Healthcare Center-I Ambulatory, in Bauru. We did not confirm the low cholesterol level referred in many surveys and the obtained value for the HDL cholesterol was remarkabally different from data found among lepromatous leprosy patients in India. Fibrinolytic activity is significantly decreased in patients of lepromatous leprosy and in erythema nodosum leprosum 29,30,31,48,49. Plasminogen and
apolipoprotein(a) are also genetically linked on human chromosome 6, and partial amino acid sequence of both is homologous21 . Based upon our labotatory data we suggest the importance of lipoprotein(a) in determining the cardiovascular disease risk and fibrinolytic activity alteration in lepromatous leprosy patients. Because we found highly increased blood levels of lipoprotein(a) wen present data were compared to data found in previous surveys.
References
1-ALBERS, J. J. ; MARCOVINA, S.M. & LODGE, M.S. The Unique Lipoprotein(a): Properties and Immunochemical Measurement. Clin.Chem., v. 36(12), p. 2019-2026, 1990.
2-ALBERS, J.J. ; WAHL, P.W. ; CABANA, V.G. ; et al. Quantitation of Apolipoprotein A-I of Human Plasma High Density Lipoprotein. Metabolism, v. 25(6), p. 633-644, 1976.
3-AHALEY, S.K. ; SARDESHMUKH, A.S. ; SURYAKAR, A.N.; et al. Correlation of Serum Lipids and Lipoproteins in Leprosy. Indian J. Lepr. , v. 64(1), p. 91-98, 1992.
4-ASSMANN, G. ; SCHRIEWER , H.; SCHMITZ, G.; et al. Quantification of High-Density-Lipoprotein Cholesterol by Precipitation wi th Phosphotungstic
Acid/MgCI2. Clin. Chem., v. 29(12), p. 2026-2030, 1983.
5-BERG, K. ; DAHLEN, G. & BORRESEN, A. Lp(a) phenotypes, other lipoprotein parameters, and a family history of coronary heart disease in middle-aged males. Clin. Genet., v. 16, p. 347-352, 1979
6-BHUSHAM, B. ; KAUR, S.; GEORGE, T.; et al. Serum lipids in leprosy. Lepr. India, v. 52(3), p. 433-439, 1980.
7-BLUM, C.R. ; LEVY, R.I.; EISENBERG,S.; et al. High-Density Lipoprotein Metabolism in Man. I. Clin. Invest., v. 60, p. 795-807, 1977.
8-BROWN, M.S. ; KOVANEN, P.T. & GOLDSTEIN, J.L. Regulation of Plasma Cholesterol by Lipoprotein Receptors. Science, v. 212, p. 628-635, 1981.
9-BROWN, M.S. & GOLDSTEIN, J.L. Lipoprotein Metabolism in the macrophage: Implications for Cholesterol Deposition in Atherosclerosis. Ann. Review Biochem., v. 52, p. 223-261, 1983.
10-CASTELLI, W.P.; DOYLE, J.T.; GORDON, T.; et al. HDL Cholesterol and Other Lipids in Coronary Heart Disease. The Cooperative Lipoprotein
Phenotyping Study. Circulation, v. 55, p. 767-772, 1977.
11-COLDITZ, G.A. ; BONITA, R. ; STAMPFER, M.J.; et al. Cigarette Smoking and Risk of Stroke in Middle-Aged Women. N. 6íg1. I. Med. , v. 318(15), p. 937-941, 1988.
12-DAHLEN, G.H. ; GUYTON, J.R. ; ATTAR, M.; et al. Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary
artery disease documented by angiography. Circulation, v. 74(4), p. 758-765, 1986.
13-EATON, D.L. ; FLESS, G.M. ; KOHR, W.J.; et al. Partial amino acid sequence of apolipoprotein(a) shows that it is homologous to plasminogen. Proc. Natl. Acad. Sci. U.S.A., v. 84, p. 3224-3228, 1987.
14-EDELBERG, J.M. ; GONZALES-GRONOW, M. & PIZZO, S.V. Lipoprotein(a) Inhibits Streptokinase-Mediated Activation of Human Plasminogen.
Biochemistry, v. 28, p. 2370-2374, 1989.
15-EDER, H.A. & GIDEZ, L.I. The Clinical Significance of the Plasma High Density Lipoproteins. Med. Clin. North Am., v. 66(2), p. 431-439, 1982.
16-FRANK, S.L. ; KLISAK, I. ; SPARKES, R.S.; et al. The apolipoprotein(a) gene resides on human chromosome 6q26-27, in close proximity to the
homologous gene for plasminogen. Hum. Genet., v. 79, p. 352-356, 1988.
17-FUSTER, V. ; BADINOM, L. ; BADINOM, J.J.; et al. The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes.(First of Two Parts). N. Engl. I. Med., v. 326(4), p. 242-250, 1992.
18-FUSTER, V.; BADINOM, L.; BADINOM, J.J.; et al. The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes.(Second of Two Parts) N. Engl. I. Med., v. 326(5), p. 310-318, 1992.
19-GAUBATZ, J.W.; HEIDEMAN, C. ; GOTTO Jr.; et al. Human Plasma Lipoprotein(a). I. Biol. Chem., v. 258(7), p. 4582-4589, 1983.
20-GIRARD, G. & WOLTZ, H. La cholesterolemie chez les lepreux de Madagascar. Inter. J. Lepr., v. 2(4), p. 492,1934.
21-GONZALES-GRONOW, M.; EDELBERG, J.M. & PIZZO, S.V. Further Characterization of the Cellular Plasminogen Binding Site: Evidence That Plasminogen 2 and Lipoprotein a Compete for the Same Site. Biochemistry, v. 28, p. 2374-2377, 1898.
22-GORDON, T. ; CASTELLI, W.P.; HJORTLAND, M.C.; et al. High Density Lipoprotein As a Protective Factor Against Coronary Heart Disease. The Framinghan Study. Am. I. Med., v. 62, p. 707-14, 1977.
23-GOTT Jr, A.M. A Symposium: New Directions in Tratament of Patients at Risk of Coronary Artery Disease. Am.J.Cardiol., v. 57(14), p. 10-11, 1986.
24-HAJJAR, K.A. ; GAVISH, D. ; BRESLOW, J.L.; et al. Lipoprotein(a) modulation of endothelial cell surface fibrinolysis and its potential role in
atherosclerosis. Nature, v. 339, p. 303-305, 1989.
25-HAARBO, J. ; HASSAGER, C. ; SCHLEMMER, A.; et al. Influence of smoking, body fat distribution, and alcohol consumption on serum lipids, lipoproteins, and apolipoproteins in early postmenopausal women. Atherosclerosis, v. 84, p. 239-244, 1990.
26-HARIPRASAD, Ch.; RAMA RAO, A.V.S.S.; SYAMASUNDARA, P.; et al. Serum Beta Lipoprotein Levels in Leprosy. Inter. I. Lepr., v. 39(4), p. 896-897, 1970.
27-HAVEL, R.J. ; KANE, J.P. & KASHYAP, M.L. Interchange of Apol ipoproteins betwen Chylomicrons and High Density Lipoproteins during Alimentary Lipemia in Man. I. Clin Invest, v. 52, p. 33-38, 1973.
28-HJERMANN, I. ; HOLME, I.; VELVE BYRE, K. ; et al. Effect of diet and smoking intervention on the incidence of coronary heart disease. Lancet, v. II, p. 1303-1310, 1981.
29-IZAKI, M. & KON, S. Fibrinolytic phenomenon in erythema nodosum leprosum - with special reference to its pathogenesis and treatment. Abstrat No. 166, Transactions of the Ninth International Leprosy Congress, London, September 1968. Int. 1. Lepr. v. 36(4); p.639, 1968.
30-JADHAV, V.H. ; JADHAV, M.V. ; SAPATNEKAR, S.M.; et al. Fibrinolytic Phenomenon in Leprosy. Indian I. Lepr. , v. 62(2), p. 208-214, 1990.
31-JAIN, V.K. ; VERMA, K.C. & AGGARWAL, S.S. A Study of Serum Fibrinolytic Activity in Erythema Nodosum Leprosum( ENL). Lepr India, v. 55(1): p. 95-107, 1983.
32-KARADI, I. ; KOSTNER, G.M. ; GRIES, A. ; et al. L i p o p r o t e i n ( a ) a n d p l a smi n o g e n a r e immunochemically related. Biochem. Biophys. Acta, v. 960, p. 91-97, 1988.
33-KREMPLER, F. ; KOSTNER, G. ; BOLZANO, K.; et al. Studies on the Metabolism of Lipoprotein Lp(a) In Man. Atherosclerosis, v. 30, p. 57-65, 1978.
34-KREMPLER, F. ; KOSTNER, G.M.; BOLZANO, K.; et al. Turnover of Lipoprotein(a) in Man. I. Clin. Invest., v. 65(6), p. 1483-1490, 1980.
35-KREMPLER, F. ; KOSTNER, G.M. ; ROSCHER, A. ;et al. Studies on the Role of Specific Cell Surface Receptors in the Removal of Lipoprotein(a) in Man. 1. Clin. Invest., v. 71(5), p. 1431-1441, 1983.
36-KUMAR, N. ; SARASWAI, P.K. & SHANKER, A. E s t ima t i o n o f h i g h d e n s i t y l i p o p r o t e i n cholesterol in the diagnosis of lepromatous
leprosy. Ind. . Lepr. , v. 60(4), p. 600-603, 1988.
37-LAKIER, J.B. Smoking and Cardiovascular Disease Am. . Med., v. 93(1A), p. 85-125, 1992.
38-LOPES-VIRELLA, M.F.; STONE, I'.; ELLIS, S.; et al. Cholesterol Determination in High Density Lipoproteins Separated by Three Dif ferent Methods. Clin. Chem., v. 23(5), p. 882-884, 1977.
39-LOSCALZO, J. ; WEINFELD, M. ; FLESS, G.M.; et al. Lipoprotein(a), Fibrin Binding, and Plasminogen Activation. Atherosclerosis, v. 10(2), p. 240-245,
1990.
40-MAEDA, S. ; ABE, A. ; SEISHIMA, M.; et al. Transient changes of serum lipoprotein(a) as an acute phase protein. Atherosclerosis, v. 78, p. 145-150, 1989.
41-MARANHÃO, R.C. ; ARIE, S. ; VINAGRE, C.G.C. ; et al. Níveis plasmáticos de Lipoproteína(a) em indivíduos normais e portadores de doença coronariana confirmada por cinecoronario-grafia. Arq. Bras. Cardiol, v. 56(2), p. 121-125, 1991.
42-MARTINEZ, T.L.R.; AURIEMO, C.R.C.; BERTINIOLIVEIRA, A.M.; et al. Considerações básicas sobre a bioquímica, metabolismo e avaliação laboratorial das lipoproteínas. Rev. Bras. Pat. Clin., v. 20(6), p.177-184, 1984.
43-MARTINEZ, T.L.R.; PINTO, L.E.S.A.; MALDJIAN, S.; et al. Lipoproteínas-Fisiologia. Laes, v. 61, p. 18. 28, 1989.
44-MARTINEZ, T.L.R. ; PINTO, L.E.S.A.; SILVA, A.M.A.P.N.; et al. Lipoproteínas: formas menos freqüentes de dislipidemias. Laos, v. 64, p.12-18, 1990.
45 -MBEWU, A.D. & DURRINGTON, P.N. L i p o - protein(a): structure, properties and possible involvement in thrombogenesis and atherogenesis.
Atherosclerosis, v. 85, p. 1-14, 1990.
46-McLEAN, J.W. ; TOMLINSON, J.E. ; KUANG, W.I.; et al . cDNA sequ ence of human apol i p oprotei n(a) is homol ogous to plasmi nogen. Nature, v. 300, p.132-137, 1987.
47-MEYERS, W.M. Impairment of Plasma Fibrinolytic Activity in Leprosy Patients. Int. . Lepr. v. 37(4), p. 343-350, 1969.
48- MEYERS, W.M. Plasma Heparin-Precipitable Fraction in Leprosy Patients. Int. . Lepr., v. 36(2): p. 192-202, 1968.
49-MILLER, G.I. & MILLER, N.E. Plasma-high-densitylipoprotein concentration and development of ischaemic heart-disease. Lancet, v. 1: p. 16-19, 1975.
50-MILES, L.A. ; FLESS, G.M. ; LEVIN, E.G. ; et al. A potential basis for the thrombotic risks associated with lipoprotein(a). Nature, v. 339, v. 301-313, 1989.
51-MONTENEGRO, M.R. - A Aterosclerose em São Paulo. II- Aterosclerose na aorta e nas artérias coronárias. Rev. Inst. Med. Trop. São Paulo , v.9(2), p. 107-124, março-abril, 1967.
52-MONTENEGRO, M.R. Patogenia da Aterosclerose. Laos, v. 69, p. 24-31, 1991.
53-MURAI, A. ; MIYAHARA, T. ; FUJIMOTO, N. ; et al. Lp(a) Lipoprotein as a Risk Factor for Coronary He a r t Di s e a s e a n d Ce r e b r a l In f a r c t i o n .
Atherosclerosis, v. 59, p. 199-204, 1986.
54-OPROMOLLA, D.V.A. História da hanseníase. In: Noções de Hanseníase. Parte I. Hospital Lauro de Souza Lima, 1981: 1-9, 84-95.
55-OPROMOLLA, D.V.A. ; TONELLO, C. ; FLEURY, R.N. & BASTAZINI, I. Embolia Pulmonar no decurso de Reação Hansênica. Hansen. Int, v. 2(2), p. 178-
183, 1977.
56-PARKER, F. Xantomas e Hiperlipidemias- . Am. Acad. Dermatol. v. 13(1), p. 1-30, 1985.
57-RATH DE SOUZA, P. & ALAYON, F. Sobre a presença de lipídios nas lesões cutâneas da lepra. Rev. Brasileira Leprol. v. 10, p. 369-401, 1942.
58-ROGERS, J.H. Coronary thrombosis, cerebral vascular accident and pulmonary embolism in leprosy Int. . Lepr., v. 29(4), p. 538, 1961.
59-SANNAZZARO, C.A.C. & GUNTER HOXTER - Deslipemias. Laes, v. 59, p. 50-61, 1989.
60-SEED, M. ; HOPPICHLER, F. ; REAVELEY, D. ; McCARTHY, S. ; et al . Rel at ion of serum lipoprotein(a) concentration and apolipoprotein(a)
phenotype to coronary heart disease in patients with familial hypercholesterolemia. N. Engl. . Med., v. 322(21), p. 1494-1499, 1990.
61-SIEDEL, I. ; HAGELE, E.O.; ZIEGENHORN, J.; et al. Reagent for the Enzymatic Determination of Serum Total Cholesterol with Improved Lipolytic Efficiency. Clin. Chem., v. 29(6), p. 1075-1080, 1983.
62-SRITHARAN, K. ; VENKATESAN, K.; BHARADWAJ, V.P. & RAMU, G. Serum lipids profile in leprosy. Lepr. India, v. 51(4), p. 515-520, 1979.
63-TALL, A.R. & SMALL, D.M. Plasma High Density Lipoproteins. N. Engl. . Med., v. 299(22), p. 1232-1236, 1978.
64-UTERMANN, G. ; HOPPICHLER, F. ; DIEPLINGER, H. ; et al. Defects in the low density lipoprotein receptor gene affect lipoprotein(a) levels:
Multipl icative interact ion of two gene loci associated with premature atherosclerosis. Proc. Natl. Acad. Sci. U.S.A.. v. 86, p. 4171-4. 1989.
65-UTERMANN, G. The Mysteries of Lipoprotein(a). Science, v. 246, p. 904-910, 1989.
66-WARNICK, G.R. & ALBERS, J.J. A comprehensive e v a l u a t i o n o f t h e h e p a r i n -ma n g a n e s e precipitation procedure for est imating high
density lipoprotein cholesterol. J. Lipid Res., v. 19, p. 65-76, 1978.
67-WILSON, P. W. F.; GARRISON, R.J. & CASTELLI, W.P. Postmenopausal estrogen use, cigarrette smok i ng, and cardi ovascul ar morbi di t y i n women over 50. The Framinghan Study. N. Engl. . Med., v. 313(17), p. 1038-1043, 1985.
68-WRIGHT, L.C. ; SULLIVAN, D.R. ; MULLER, M. ; et al. Elevated apolipoprotein(a) levels in cancer patients. Int. I. Cancer, v. 43, p. 241-244, 1989
2-ALBERS, J.J. ; WAHL, P.W. ; CABANA, V.G. ; et al. Quantitation of Apolipoprotein A-I of Human Plasma High Density Lipoprotein. Metabolism, v. 25(6), p. 633-644, 1976.
3-AHALEY, S.K. ; SARDESHMUKH, A.S. ; SURYAKAR, A.N.; et al. Correlation of Serum Lipids and Lipoproteins in Leprosy. Indian J. Lepr. , v. 64(1), p. 91-98, 1992.
4-ASSMANN, G. ; SCHRIEWER , H.; SCHMITZ, G.; et al. Quantification of High-Density-Lipoprotein Cholesterol by Precipitation wi th Phosphotungstic
Acid/MgCI2. Clin. Chem., v. 29(12), p. 2026-2030, 1983.
5-BERG, K. ; DAHLEN, G. & BORRESEN, A. Lp(a) phenotypes, other lipoprotein parameters, and a family history of coronary heart disease in middle-aged males. Clin. Genet., v. 16, p. 347-352, 1979
6-BHUSHAM, B. ; KAUR, S.; GEORGE, T.; et al. Serum lipids in leprosy. Lepr. India, v. 52(3), p. 433-439, 1980.
7-BLUM, C.R. ; LEVY, R.I.; EISENBERG,S.; et al. High-Density Lipoprotein Metabolism in Man. I. Clin. Invest., v. 60, p. 795-807, 1977.
8-BROWN, M.S. ; KOVANEN, P.T. & GOLDSTEIN, J.L. Regulation of Plasma Cholesterol by Lipoprotein Receptors. Science, v. 212, p. 628-635, 1981.
9-BROWN, M.S. & GOLDSTEIN, J.L. Lipoprotein Metabolism in the macrophage: Implications for Cholesterol Deposition in Atherosclerosis. Ann. Review Biochem., v. 52, p. 223-261, 1983.
10-CASTELLI, W.P.; DOYLE, J.T.; GORDON, T.; et al. HDL Cholesterol and Other Lipids in Coronary Heart Disease. The Cooperative Lipoprotein
Phenotyping Study. Circulation, v. 55, p. 767-772, 1977.
11-COLDITZ, G.A. ; BONITA, R. ; STAMPFER, M.J.; et al. Cigarette Smoking and Risk of Stroke in Middle-Aged Women. N. 6íg1. I. Med. , v. 318(15), p. 937-941, 1988.
12-DAHLEN, G.H. ; GUYTON, J.R. ; ATTAR, M.; et al. Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary
artery disease documented by angiography. Circulation, v. 74(4), p. 758-765, 1986.
13-EATON, D.L. ; FLESS, G.M. ; KOHR, W.J.; et al. Partial amino acid sequence of apolipoprotein(a) shows that it is homologous to plasminogen. Proc. Natl. Acad. Sci. U.S.A., v. 84, p. 3224-3228, 1987.
14-EDELBERG, J.M. ; GONZALES-GRONOW, M. & PIZZO, S.V. Lipoprotein(a) Inhibits Streptokinase-Mediated Activation of Human Plasminogen.
Biochemistry, v. 28, p. 2370-2374, 1989.
15-EDER, H.A. & GIDEZ, L.I. The Clinical Significance of the Plasma High Density Lipoproteins. Med. Clin. North Am., v. 66(2), p. 431-439, 1982.
16-FRANK, S.L. ; KLISAK, I. ; SPARKES, R.S.; et al. The apolipoprotein(a) gene resides on human chromosome 6q26-27, in close proximity to the
homologous gene for plasminogen. Hum. Genet., v. 79, p. 352-356, 1988.
17-FUSTER, V. ; BADINOM, L. ; BADINOM, J.J.; et al. The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes.(First of Two Parts). N. Engl. I. Med., v. 326(4), p. 242-250, 1992.
18-FUSTER, V.; BADINOM, L.; BADINOM, J.J.; et al. The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes.(Second of Two Parts) N. Engl. I. Med., v. 326(5), p. 310-318, 1992.
19-GAUBATZ, J.W.; HEIDEMAN, C. ; GOTTO Jr.; et al. Human Plasma Lipoprotein(a). I. Biol. Chem., v. 258(7), p. 4582-4589, 1983.
20-GIRARD, G. & WOLTZ, H. La cholesterolemie chez les lepreux de Madagascar. Inter. J. Lepr., v. 2(4), p. 492,1934.
21-GONZALES-GRONOW, M.; EDELBERG, J.M. & PIZZO, S.V. Further Characterization of the Cellular Plasminogen Binding Site: Evidence That Plasminogen 2 and Lipoprotein a Compete for the Same Site. Biochemistry, v. 28, p. 2374-2377, 1898.
22-GORDON, T. ; CASTELLI, W.P.; HJORTLAND, M.C.; et al. High Density Lipoprotein As a Protective Factor Against Coronary Heart Disease. The Framinghan Study. Am. I. Med., v. 62, p. 707-14, 1977.
23-GOTT Jr, A.M. A Symposium: New Directions in Tratament of Patients at Risk of Coronary Artery Disease. Am.J.Cardiol., v. 57(14), p. 10-11, 1986.
24-HAJJAR, K.A. ; GAVISH, D. ; BRESLOW, J.L.; et al. Lipoprotein(a) modulation of endothelial cell surface fibrinolysis and its potential role in
atherosclerosis. Nature, v. 339, p. 303-305, 1989.
25-HAARBO, J. ; HASSAGER, C. ; SCHLEMMER, A.; et al. Influence of smoking, body fat distribution, and alcohol consumption on serum lipids, lipoproteins, and apolipoproteins in early postmenopausal women. Atherosclerosis, v. 84, p. 239-244, 1990.
26-HARIPRASAD, Ch.; RAMA RAO, A.V.S.S.; SYAMASUNDARA, P.; et al. Serum Beta Lipoprotein Levels in Leprosy. Inter. I. Lepr., v. 39(4), p. 896-897, 1970.
27-HAVEL, R.J. ; KANE, J.P. & KASHYAP, M.L. Interchange of Apol ipoproteins betwen Chylomicrons and High Density Lipoproteins during Alimentary Lipemia in Man. I. Clin Invest, v. 52, p. 33-38, 1973.
28-HJERMANN, I. ; HOLME, I.; VELVE BYRE, K. ; et al. Effect of diet and smoking intervention on the incidence of coronary heart disease. Lancet, v. II, p. 1303-1310, 1981.
29-IZAKI, M. & KON, S. Fibrinolytic phenomenon in erythema nodosum leprosum - with special reference to its pathogenesis and treatment. Abstrat No. 166, Transactions of the Ninth International Leprosy Congress, London, September 1968. Int. 1. Lepr. v. 36(4); p.639, 1968.
30-JADHAV, V.H. ; JADHAV, M.V. ; SAPATNEKAR, S.M.; et al. Fibrinolytic Phenomenon in Leprosy. Indian I. Lepr. , v. 62(2), p. 208-214, 1990.
31-JAIN, V.K. ; VERMA, K.C. & AGGARWAL, S.S. A Study of Serum Fibrinolytic Activity in Erythema Nodosum Leprosum( ENL). Lepr India, v. 55(1): p. 95-107, 1983.
32-KARADI, I. ; KOSTNER, G.M. ; GRIES, A. ; et al. L i p o p r o t e i n ( a ) a n d p l a smi n o g e n a r e immunochemically related. Biochem. Biophys. Acta, v. 960, p. 91-97, 1988.
33-KREMPLER, F. ; KOSTNER, G. ; BOLZANO, K.; et al. Studies on the Metabolism of Lipoprotein Lp(a) In Man. Atherosclerosis, v. 30, p. 57-65, 1978.
34-KREMPLER, F. ; KOSTNER, G.M.; BOLZANO, K.; et al. Turnover of Lipoprotein(a) in Man. I. Clin. Invest., v. 65(6), p. 1483-1490, 1980.
35-KREMPLER, F. ; KOSTNER, G.M. ; ROSCHER, A. ;et al. Studies on the Role of Specific Cell Surface Receptors in the Removal of Lipoprotein(a) in Man. 1. Clin. Invest., v. 71(5), p. 1431-1441, 1983.
36-KUMAR, N. ; SARASWAI, P.K. & SHANKER, A. E s t ima t i o n o f h i g h d e n s i t y l i p o p r o t e i n cholesterol in the diagnosis of lepromatous
leprosy. Ind. . Lepr. , v. 60(4), p. 600-603, 1988.
37-LAKIER, J.B. Smoking and Cardiovascular Disease Am. . Med., v. 93(1A), p. 85-125, 1992.
38-LOPES-VIRELLA, M.F.; STONE, I'.; ELLIS, S.; et al. Cholesterol Determination in High Density Lipoproteins Separated by Three Dif ferent Methods. Clin. Chem., v. 23(5), p. 882-884, 1977.
39-LOSCALZO, J. ; WEINFELD, M. ; FLESS, G.M.; et al. Lipoprotein(a), Fibrin Binding, and Plasminogen Activation. Atherosclerosis, v. 10(2), p. 240-245,
1990.
40-MAEDA, S. ; ABE, A. ; SEISHIMA, M.; et al. Transient changes of serum lipoprotein(a) as an acute phase protein. Atherosclerosis, v. 78, p. 145-150, 1989.
41-MARANHÃO, R.C. ; ARIE, S. ; VINAGRE, C.G.C. ; et al. Níveis plasmáticos de Lipoproteína(a) em indivíduos normais e portadores de doença coronariana confirmada por cinecoronario-grafia. Arq. Bras. Cardiol, v. 56(2), p. 121-125, 1991.
42-MARTINEZ, T.L.R.; AURIEMO, C.R.C.; BERTINIOLIVEIRA, A.M.; et al. Considerações básicas sobre a bioquímica, metabolismo e avaliação laboratorial das lipoproteínas. Rev. Bras. Pat. Clin., v. 20(6), p.177-184, 1984.
43-MARTINEZ, T.L.R.; PINTO, L.E.S.A.; MALDJIAN, S.; et al. Lipoproteínas-Fisiologia. Laes, v. 61, p. 18. 28, 1989.
44-MARTINEZ, T.L.R. ; PINTO, L.E.S.A.; SILVA, A.M.A.P.N.; et al. Lipoproteínas: formas menos freqüentes de dislipidemias. Laos, v. 64, p.12-18, 1990.
45 -MBEWU, A.D. & DURRINGTON, P.N. L i p o - protein(a): structure, properties and possible involvement in thrombogenesis and atherogenesis.
Atherosclerosis, v. 85, p. 1-14, 1990.
46-McLEAN, J.W. ; TOMLINSON, J.E. ; KUANG, W.I.; et al . cDNA sequ ence of human apol i p oprotei n(a) is homol ogous to plasmi nogen. Nature, v. 300, p.132-137, 1987.
47-MEYERS, W.M. Impairment of Plasma Fibrinolytic Activity in Leprosy Patients. Int. . Lepr. v. 37(4), p. 343-350, 1969.
48- MEYERS, W.M. Plasma Heparin-Precipitable Fraction in Leprosy Patients. Int. . Lepr., v. 36(2): p. 192-202, 1968.
49-MILLER, G.I. & MILLER, N.E. Plasma-high-densitylipoprotein concentration and development of ischaemic heart-disease. Lancet, v. 1: p. 16-19, 1975.
50-MILES, L.A. ; FLESS, G.M. ; LEVIN, E.G. ; et al. A potential basis for the thrombotic risks associated with lipoprotein(a). Nature, v. 339, v. 301-313, 1989.
51-MONTENEGRO, M.R. - A Aterosclerose em São Paulo. II- Aterosclerose na aorta e nas artérias coronárias. Rev. Inst. Med. Trop. São Paulo , v.9(2), p. 107-124, março-abril, 1967.
52-MONTENEGRO, M.R. Patogenia da Aterosclerose. Laos, v. 69, p. 24-31, 1991.
53-MURAI, A. ; MIYAHARA, T. ; FUJIMOTO, N. ; et al. Lp(a) Lipoprotein as a Risk Factor for Coronary He a r t Di s e a s e a n d Ce r e b r a l In f a r c t i o n .
Atherosclerosis, v. 59, p. 199-204, 1986.
54-OPROMOLLA, D.V.A. História da hanseníase. In: Noções de Hanseníase. Parte I. Hospital Lauro de Souza Lima, 1981: 1-9, 84-95.
55-OPROMOLLA, D.V.A. ; TONELLO, C. ; FLEURY, R.N. & BASTAZINI, I. Embolia Pulmonar no decurso de Reação Hansênica. Hansen. Int, v. 2(2), p. 178-
183, 1977.
56-PARKER, F. Xantomas e Hiperlipidemias- . Am. Acad. Dermatol. v. 13(1), p. 1-30, 1985.
57-RATH DE SOUZA, P. & ALAYON, F. Sobre a presença de lipídios nas lesões cutâneas da lepra. Rev. Brasileira Leprol. v. 10, p. 369-401, 1942.
58-ROGERS, J.H. Coronary thrombosis, cerebral vascular accident and pulmonary embolism in leprosy Int. . Lepr., v. 29(4), p. 538, 1961.
59-SANNAZZARO, C.A.C. & GUNTER HOXTER - Deslipemias. Laes, v. 59, p. 50-61, 1989.
60-SEED, M. ; HOPPICHLER, F. ; REAVELEY, D. ; McCARTHY, S. ; et al . Rel at ion of serum lipoprotein(a) concentration and apolipoprotein(a)
phenotype to coronary heart disease in patients with familial hypercholesterolemia. N. Engl. . Med., v. 322(21), p. 1494-1499, 1990.
61-SIEDEL, I. ; HAGELE, E.O.; ZIEGENHORN, J.; et al. Reagent for the Enzymatic Determination of Serum Total Cholesterol with Improved Lipolytic Efficiency. Clin. Chem., v. 29(6), p. 1075-1080, 1983.
62-SRITHARAN, K. ; VENKATESAN, K.; BHARADWAJ, V.P. & RAMU, G. Serum lipids profile in leprosy. Lepr. India, v. 51(4), p. 515-520, 1979.
63-TALL, A.R. & SMALL, D.M. Plasma High Density Lipoproteins. N. Engl. . Med., v. 299(22), p. 1232-1236, 1978.
64-UTERMANN, G. ; HOPPICHLER, F. ; DIEPLINGER, H. ; et al. Defects in the low density lipoprotein receptor gene affect lipoprotein(a) levels:
Multipl icative interact ion of two gene loci associated with premature atherosclerosis. Proc. Natl. Acad. Sci. U.S.A.. v. 86, p. 4171-4. 1989.
65-UTERMANN, G. The Mysteries of Lipoprotein(a). Science, v. 246, p. 904-910, 1989.
66-WARNICK, G.R. & ALBERS, J.J. A comprehensive e v a l u a t i o n o f t h e h e p a r i n -ma n g a n e s e precipitation procedure for est imating high
density lipoprotein cholesterol. J. Lipid Res., v. 19, p. 65-76, 1978.
67-WILSON, P. W. F.; GARRISON, R.J. & CASTELLI, W.P. Postmenopausal estrogen use, cigarrette smok i ng, and cardi ovascul ar morbi di t y i n women over 50. The Framinghan Study. N. Engl. . Med., v. 313(17), p. 1038-1043, 1985.
68-WRIGHT, L.C. ; SULLIVAN, D.R. ; MULLER, M. ; et al. Elevated apolipoprotein(a) levels in cancer patients. Int. I. Cancer, v. 43, p. 241-244, 1989
This work is licensed under a Creative Commons Attribution 4.0 International License.
Downloads
Download data is not yet available.
